Feasibility of using ultrasound contrast agents to increase the size of thermal lesions induced by non-focused transducers: in vitro demonstration in tissue mimicking phantom.
Miniature flat ultrasound transducers have shown to be effective for a large variety of thermal therapies, but the associated superficial heating implicates developing original strategies in order to extend therapeutic depth. The goal of the present paper is to use ultrasound contrast agents (UCA) to increase remote attenuation and heating. Theoretical simulations demonstrated that increasing attenuation from 0.27 to 0.8 Np/cm at 10 MHz beyond a distance of 18 mm from the transducer should result in longer thermal damages due to protein coagulation in a tissue mimicking phantom. Contrast agents (BR14, Bracco, Plan-les-Ouates, Switzerland) were embedded in thermo-sensitive gel and attenuations ranging from 0.27 to 1.33 Np/cm were measured at 10 MHz for concentrations of BR14 between 0 and 4.8%. Thermal damages were then induced in several gels, which had different layering configurations. Thermal damages, 12.8mm in length, were obtained in homogeneous gels. When mixing contrast agents at a concentration of 3.2% beyond a first 18 mm-thick layer of homogeneous gel, the thermal damages reached 21.5mm in length. This work demonstrated that contrast agents can be used for increasing attenuation remotely and extending therapeutic depth induced by a non-focused transducer. Additional work must be done in vivo in order to verify the remote-only distribution of bubbles and associated increase in attenuation.
Lafon
Cyril
C
INSERM, U556, Lyon, F-69003, France. cyril.lafon@inserm.fr
Murillo-Rincon
Adriana
A
Goldenstedt
Cédric
C
Chapelon
Jean Yves
JY
Mithieux
François
F
Owen
Neil R
NR
Cathignol
Dominique
D
D017115:Catheter Ablation / Q000379:methods*; D005240:Feasibility Studies; D005466:Fluorocarbons / Q000737:chemistry*; D005782:Gels; D008962:Models, Theoretical; D019047:Phantoms, Imaging; D010743:Phospholipids / Q000737:chemistry*; D014159:Transducers; D014464:Ultrasonic Therapy / Q000295:instrumentation* / Q000379:methods*
C471302:BR14 contrast agent; D005466:Fluorocarbons; D005782:Gels; D010743:Phospholipids